Articles > Abbott

Freestyle Libre CGM Aided Blood Sugar Management of Homebound Patients with Diabetes

Two U.K. case-based studies found evidence that use of the devices helped uncover bouts of low blood sugar among frail, elderly patients.

ollaborations Announced Between Sanofi and Abbott, and Between Novo Nordisk and Medtronic

The two separate collaborations will soon allow the companies to make more readily available blood sugar readings and insulin dosing information across more diabetes devices, apps, and platforms.

Anticipating Rising Demand Worldwide, Abbott Aims to Boost Production of Freestyle Libre System

The medical device maker is hoping to keep costs down and increase access to its novel glucose monitoring device.